Gliadel 7.7 mg/1 (Carmustine WAFER) 7.7 mg/1

Gliadel 7.7 mg/1 is a carmustine wafer designed for intracavitary use. It is used in specific medical treatments and is manufactured by Azurity Pharmaceuticals, Inc. in the USA.

Strength

7.7 mg/1

Pack Size

8 POUCH in 1 BOX (24338-050-08) / 1 WAFER in 1 POUCH

Manufacturer / TM Owner

Azurity Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gliadel 7.7 mg/1 wafers are typically used in conjunction with surgical procedures for certain types of brain tumors. These wafers are designed to deliver carmustine directly to the affected area, providing localized treatment. The primary use of Gliadel wafers is to help manage the growth of malignant gliomas, a type of brain tumor. Patients and healthcare providers often seek information on what Gliadel wafers are used for and how they can be integrated into a treatment plan.

Side Effects

Gliadel 7.7 mg/1 wafers are intended to provide localized delivery of carmustine, which may help in reducing tumor growth. Common effects associated with the use of these wafers can include localized reactions at the site of application. Patients may experience varying degrees of these effects, and it is important to discuss any concerns with a healthcare professional.

Precautions & Warnings

When handling Gliadel 7.7 mg/1 wafers, it is crucial to follow the instructions provided by the healthcare professional. Proper storage and administration techniques should be adhered to in order to ensure the effectiveness and safety of the treatment. Patients should be aware of any potential allergic reactions or sensitivities to the components of the wafer.

Avoid Interactions

Gliadel 7.7 mg/1 wafers may interact with other medications or treatments, particularly those that affect the immune system or blood clotting. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, certain foods or supplements may also interact with the wafers, so it is advisable to discuss your diet with your healthcare provider.

References

Frequently Asked Questions

Gliadel 7.7 mg/1 wafers are used in the treatment of certain types of brain tumors, specifically malignant gliomas, in conjunction with surgical procedures.

Gliadel wafers are administered intracavitarily, typically during surgery, to deliver carmustine directly to the affected area.

Common effects may include localized reactions at the site of application, and patients may experience varying degrees of these effects.

Yes, it is important to follow the instructions provided by your healthcare professional, including proper storage and administration techniques.

Yes, Gliadel wafers may interact with other medications, particularly those that affect the immune system or blood clotting.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.